Key result
Catecholamine-induced tachyarrhythmias develop in ~11% of pheochromocytoma patients, led by sinus tachycardia and AF.
Why the study?
Catecholamine-induced tachyarrhythmias in pheochromocytoma arise from catecholamine excess rather than a primary electrophysiologic substrate, requiring special considerations for treatment and complication avoidance based on their underlying pathophysiology.
Optimal acute management of pheochromocytoma-induced tachyarrhythmias requires tailoring adrenoceptor blockade and antiarrhythmic therapy to the tumor's biochemical phenotype and the patient's blood pressure to prevent life-threatening hypertensive crises or hypotensive shock.
Pheochromocytomas, arising from chromaffin cells, produce catecholamines, epinephrine and norepinephrine. The tumor biochemical phenotype is defined by which of these exerts the greatest influence on the cardiovascular system when released into circulation in high amounts. Action on the heart and vasculature can cause potentially lethal arrhythmias, often in the setting of comorbid blood pressure derangements. In a review of electrocardiograms obtained on pheochromocytoma patients (n = 650) treated at our institution over the last decade, severe and refractory sinus tachycardia, atrial fibrillation, and ventricular tachycardia were found to be the most common or life-threatening catecholamine-induced tachyarrhythmias. These arrhythmias, arising from catecholamine excess rather than from a primary electrophysiologic substrate, require special considerations for treatment and complication avoidance. Understanding the synthesis and release of catecholamines, the adrenoceptors catecholamines bind to, and the cardiac and vascular response to epinephrine and norepinephrine underlies optimal management in catecholamine-induced tachyarrhythmias.
No takes yet. Share an insight, caveat, or question.
Nazari et al. (2020) conducted a review in Pheochromocytoma and catecholamine-induced tachyarrhythmias (n=650). Catecholamine excess in pheochromocytoma was evaluated on Incidence of catecholamine-induced tachyarrhythmia. Catecholamine-induced tachyarrhythmias occurred in 10.9% (71/650) of pheochromocytoma patients, with sinus tachycardia (98.6%), atrial fibrillation (11.3%), and VT (4.2%) being most common.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: